Prof. Silvia Giordani presented our latest results on drug delivery using Carbon Nano Onions at the 8th BenBedPhar COST action Scientific meeting “Thirty years since the discovery of NRF2”. The meeting took place at NOVA Medical School in Lisbon, Portugal on the 10th and 11th of October 2024.
Prof. Silvia Giordani gave a plenary lecture on “Carbon nano-onions for targeted drug delivery” at the XIII International Symposium on Nano & Supramolecular Chemistry in Sardinia, Italy
Prof. Silvia Giordani presented an invited lecture at the 34th International Conference on Diamond and Carbon Materials (ICDCM 2024) in Dresden, Germany, focusing on the tailored design of carbon nanoparticles for targeted cancer therapy.
The 9th EuChemS Chemistry Congress (ECC9), organised by the Institute of Chemistry of Ireland (ICI), was held in Dublin, Ireland, on July 7-11, 2024. All current members of the Giordani Group participated in the conference and presented their research.
The human enzyme myeloperoxidase, found majorly in the blood secreted by the immune cells (neutrophils), is capable of degrading the carbon nano-onions (CNOs) or multilayer fullerenes. The biodegradation of CNOs mainly occurs through generating radical intermediates of peroxidase and by reacting with in-situ generated hydroxy radicals under UV-light catalyzed photo-Fenton reaction.
Soapbox Science is a novel public outreach platform promoting women and non-binary scientists and their work. At this years Soapbox Science Ireland event, Prof. Silvia Giordani engaged the public with her talk on “How can Nano-onions go to the target?”.
The funding announcement by Science Foundation Ireland (SFI) was announced on Monday and has been welcomed by the delighted DCU researchers involved. The SFI Frontiers for the Future Programme provides opportunities for independent investigators to conduct innovative, collaborative research with the potential to deliver impact, whilst also providing opportunities for high-risk, high-reward research projects.
Carbon nano-onions (CNOs) are featured on this cover, illustrating a breakthrough in advanced materials for pancreatic cancer treatment. Leveraging colloid and interface science, CNOs demonstrate precise targeting and enhanced efficacy in drug delivery, offering improved therapeutic outcomes with reduced toxicity, representing a significant advancement in nanotechnology-based cancer therapies.
Sofia recently attended the BenBedPhar COST Scientific Meeting from 18th to 19th April in Tallinn. This meeting was focused on ‘Cellular Mechanisms, Disease Modeling and Clinical Approaches to NRF2 Therapeutics’. During the meeting, she presented the research that she is developing as a postdoctoral researcher in Prof. Giordani’s group, facilitating the exchange of knowledge and ideas.
In this presentation, multilayers fullerenes, also known as carbon nano-onions (CNOs), were discussed as a potential vesicle for nanocarrier-type drug delivery systems.
Relatori - Dr.ssa Michela Deleidi e s.o. Prof.ssa Silvia Giordani
La ricercatrice bergamasca Silvia Giordani, professore di Nanomateriali alla Dublin City University e il suo laboratorio hanno sperimentato con successo un nuovo metodo per il rilascio mirato dei farmaci antitumorali direttamente nelle cellule affette da adenocarcinoma pancreatico duttale.
23 gennaio 2024, compleanno di Silvia, Silvia Giordani, Professore ordinario di nanomateriali alla Dublin City University, e nostra socia che regala al suo club una affascinante conferenza sui nanomateriali.
RTÉ Radio 1 DRIVETIME Interview with Prof. Silvia Giordani
Researchers, led by Professor Silvia Giordani, School of Chemical Sciences have found a way to more precisely deliver medicines to pancreatic ductal adenocarcinoma (PDAC) cells.
DCU researcher Silvia Giordani has discovered a new method of drug delivery to treat pancreatic cancer
Prof Silvia Giordani and her team have shown how the novel delivery system can be used to target aggressive pancreatic cancer cells resistant to drugs.
Breakthrough Cancer - RESEARCH SUMMARY - Dr. Sofia Dominguez
Breakthrough Cancer - RESEARCH SUMMARY - Yingru Zhou
Join our Head of School, Professor Silvia Giordani as she takes us through the undergraduate courses on offer
Nanoparticles carrying chemotherapeutic drugs could help people with cancer escape some of the drugs’ side effects, hopes Silvia Giordani
Prof. Silvia Giordani from the School of Chemical Sciences has won an inaugural High Level Scientific Mobility Grant, a mobility scheme part of the Grants of the French Government, to strengthen scientific cooperation between Ireland and France.
“Nano Carbon Materials” research lab at the Istituto Italiano di Tecnologia in Genova, Italy.
Carbon Nanotubes: Functionalization of Carbon Nanoparticles Modulates Inflammatory Cell Recruitment and NLRP3 Inflammasome Activation
A DAY IN THE LIFE SCIENTIFIC | DUBLIN CITY OF SCIENCE 2012
Riconoscimento alla carriera ad Amalia Ercoli Finzi, per i giovani ricercatori a Silvia Giordani
During the broadcast Silvia Giordani, a researcher in Dublin originally from Bergamo, will reveal the secrets and lesser-known places of the Irish city where she lives and works today.
INNOVATION PROFILE/Science Foundation Ireland
Elevator Pitch competition entry by Silvia Giordani
ESOF2012 opens in Dublin’s National Convention Centre on Wednesday and runs until Sunday 15 July.
RTE Radio 1 MORNING IRELAND 5 min clip by TCD’s Dr Silvia Giordani
Radio Podcast on RTE Radio 1 - Mooney
Silvia Giordani gives a talk on Carbon at Carbon Barbecue as part of Culture Night 2011 in SCIENCE GALLERY, Trinity College Dublin, Ireland
An interview with Silvia Giordani in Bergamo, where the eighth edition of Bergamo Scienza takes place–an informative event with more than two hundred conferences on research and innovation
Hosted by Trinity College Dublin (TCD)
Hosted by Trinity College Dublin (TCD)